What is HeartLab?
Founded in 2018 and headquartered in Auckland, New Zealand, HeartLab provides an end-to-end solution for echocardiograms, the ultrasound tests that doctors use to examine a patient’s heart structure and function. The company's proprietary software platform automates the analysis of ultrasound imagery, providing clinicians with actionable insights to diagnose cardiovascular disease with greater precision. Beyond image processing, HeartLab streamlines the clinical workflow by automating the generation of patient reports, which are seamlessly integrated into electronic health records. This dual-focus on diagnostic accuracy and administrative efficiency places HeartLab at the intersection of medical imaging and healthtech innovation, addressing critical bottlenecks in modern cardiology departments.
How much funding has HeartLab raised?
HeartLab has raised a total of $3.3M across 2 funding rounds:
Angel/Seed
$800K
Angel/Seed
$2.5M
Angel/Seed (2020): $800K with participation from Icehouse Ventures and Founders Fund
Angel/Seed (2021): $2.5M led by Outset Ventures, Icehouse Ventures, and Founders Fund
Key Investors in HeartLab
Icehouse Ventures
A prominent New Zealand-based venture firm that has evolved from an angel network into a major early-stage investor with significant assets under management, focusing on backing ambitious Kiwi founders.
Founders Fund
A globally recognized venture capital firm known for its founder-friendly investment strategy and early support of transformative technology companies across diverse sectors.
Outset Ventures
A specialized New Zealand organization that combines deep tech venture funding with laboratory infrastructure to support the growth of high-conviction, science-led enterprises.
What's next for HeartLab?
With this major enterprise-level funding, HeartLab is poised to scale its operations and expand its footprint in international markets. The strategic capital will likely be deployed toward enhancing the platform's machine learning capabilities, further reducing the time required for diagnostic reporting, and strengthening its regulatory compliance framework to support broader adoption in major healthcare systems. As the company transitions from its early-stage development phase into a period of rapid commercial scaling, the focus will remain on deepening its integration with existing hospital infrastructure and solidifying its position as a leader in the digital cardiology space.
See full HeartLab company page
